1. Home
  2. CRL vs FBIN Comparison

CRL vs FBIN Comparison

Compare CRL & FBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • FBIN
  • Stock Information
  • Founded
  • CRL 1947
  • FBIN 1988
  • Country
  • CRL United States
  • FBIN United States
  • Employees
  • CRL N/A
  • FBIN N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • FBIN Building Products
  • Sector
  • CRL Health Care
  • FBIN Consumer Discretionary
  • Exchange
  • CRL Nasdaq
  • FBIN Nasdaq
  • Market Cap
  • CRL 7.3B
  • FBIN 6.5B
  • IPO Year
  • CRL 2000
  • FBIN N/A
  • Fundamental
  • Price
  • CRL $156.68
  • FBIN $58.74
  • Analyst Decision
  • CRL Buy
  • FBIN Buy
  • Analyst Count
  • CRL 14
  • FBIN 11
  • Target Price
  • CRL $186.00
  • FBIN $78.36
  • AVG Volume (30 Days)
  • CRL 1.1M
  • FBIN 2.0M
  • Earning Date
  • CRL 08-06-2025
  • FBIN 07-31-2025
  • Dividend Yield
  • CRL N/A
  • FBIN 1.70%
  • EPS Growth
  • CRL N/A
  • FBIN N/A
  • EPS
  • CRL N/A
  • FBIN 3.18
  • Revenue
  • CRL $4,028,615,000.00
  • FBIN $4,496,000,000.00
  • Revenue This Year
  • CRL N/A
  • FBIN $0.22
  • Revenue Next Year
  • CRL $2.49
  • FBIN $3.64
  • P/E Ratio
  • CRL N/A
  • FBIN $18.46
  • Revenue Growth
  • CRL N/A
  • FBIN N/A
  • 52 Week Low
  • CRL $91.86
  • FBIN $47.21
  • 52 Week High
  • CRL $230.02
  • FBIN $90.54
  • Technical
  • Relative Strength Index (RSI)
  • CRL 47.73
  • FBIN 61.22
  • Support Level
  • CRL $145.99
  • FBIN $54.53
  • Resistance Level
  • CRL $168.61
  • FBIN $60.76
  • Average True Range (ATR)
  • CRL 5.10
  • FBIN 1.72
  • MACD
  • CRL -1.68
  • FBIN 0.25
  • Stochastic Oscillator
  • CRL 31.41
  • FBIN 69.98

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About FBIN Fortune Brands Innovations Inc.

Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.

Share on Social Networks: